Values
Our identity
Consumer protection
Employees & partners
Mission
Environment
Code of conduct
Whistleblowing
Corporate compliance
Policy for the
Prevention of Corruption
Sustainability report
Benefit Company - B Corp
Kip for social
Corporate
Innovative PMI
Nutraceuticals
Profile and organization
Research and development
Company validations
Product certifications
and Declarations
Patents
Trademarks
KIP Academy
Quality & protection
Raw materials choice
Attention to food intolerances
Study about the packs
Information in braille
Tamper Evident system
Conservation and transportation
The nutraceutic module
Products
All products
Neurological Line
Kymax
®
Declinex
®
Uro-Gynecological Line
KIPFeR
®
Almetax
®
Almetax Easy
®
Ivuxur
®
sachets
Ivuxur
®
tablets
Miledix
®
Xinprox
®
Osteoarticular line
Dolatrox
®
Milesax
®
Xinepa
®
Xinepa Easy
®
Doltendix
®
Immunological Line
KIP
®
IMMUNO
Other products
Dolatrox hcc
®
Media
News
Press review
Company profile
Contact Media Relations
Contact
For consumers
For doctors
For pharmacies and health stores
For distributors
For other subjects
Work with us
Where we are
Legal notice
Privacy
E-commerce
Language
Italiano
English
Press review
News from the world KOLINPHARMA
12/11/2025
-
published at 10.40
Rita Paola Petrelli, interviewed by the Financial Times on the occasion of the 2026 Europe's Long-term Growth Champions award
This moment not only celebrates our journey, but also consolidates our recent prestigious recognition as Europe's Leading Long-Term Growth Company...
07/02/2025
-
published at 12.57
Kolinpharma
®
announces editorial collaboration with Edit Symposia
KOLINPHARMA
®
announces its collaboration with Edit Symposia, a prestigious editorial series of permanent updates...
05/12/2024
-
published at 16.11
Science is the best ally of health
Interview with Rita Paola Petrelli - La Repubblica
20/03/2024
-
published at 13.05
KOLINPHARMA
®
expands the range of products with the launch of Kymax
®
In recent decades, world demographics have changed significantly with a progressive aging of the global population.
10/01/2024
-
published at 13.01
Kolinpharma
®
launches KIPFeR
®
following agreement with Nemysis LTD
Kipfer is the new dietary supplement designed for all situations in which the body is deficient in iron.
Media
News
Press review
Company profile
Contact media relations
“Science accuracy and listen to people”
“Science accuracy and listen to people”